Tramadol Hydrochloride
Product Images NDC 45865-709

4 FDA label images from Medsource Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 45865-709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (709 60)

Pdp (709 60)
Label for Tramadol Hydrochloride ER capsules 150 mg by Medsource Pharmaceuticals. The label includes the product name, strength, dosage form, package quantity of 60 capsules, and manufacturer address (KLE Z INC, Los Angeles CA). It also lists warnings about dizziness, drowsiness, and alcohol avoidance, with directions for dosing in English and Spanish.*
FDA Label Image

Structural Formula (Con07 0000 01)

Structural Formula (Con07 0000 01)
Chemical structure diagram of Tramadol Hydrochloride showing its molecular formula C16H25NO2·HCl. The structure illustrates the arrangement of atoms in the active ingredient Tramadol Hydrochloride.*
FDA Label Image

Figure 2 (Con07 0000 02)

Figure 2 (Con07 0000 02)
Line graph titled 'Tramadol ER Tablets Study 023 WOMAC Pain Responder Analysis' showing percent of patients achieving various levels of pain response. The graph plots response threshold (percent improvement from baseline) on the x-axis against percent of patients achieving response on the y-axis, comparing Tramadol ER 150 mg, 200 mg, 300 mg, 400 mg, and placebo groups.*
FDA Label Image

Figure 3 (Con07 0000 03)

Figure 3 (Con07 0000 03)
A line chart depicting Tramadol ER tablets study results on arthritis pain intensity using VAS responder analysis. The graph compares percent improvement from baseline (response threshold) on the x-axis with percent of patients achieving various levels of response on the y-axis, contrasting Tramadol ER with placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.